1. Efficacy and safety of laparoscopic radical resection following neoadjuvant therapy for pancreatic ductal adenocarcinoma: A retrospective study
   Yong-Gang He et al, 2022, World Journal of Gastrointestinal Oncology CrossRef
2. The Impact of Epithelial–Mesenchymal Transition and Metformin on Pancreatic Cancer Chemoresistance: A Pathway towards Individualized Therapy
   Aiste Gulla et al, 2022, Medicina CrossRef
3. An Extensive Review on Preclinical and Clinical Trials of Oncolytic Viruses Therapy for Pancreatic Cancer
   Maryum Nisar et al, 2022, Frontiers in Oncology CrossRef
4. LncRNA MBNL1-AS1 Suppresses Cell Proliferation and Metastasis of Pancreatic Adenocarcinoma through Targeting Carcinogenic miR-301b-3p
   Chouman Sulidankazha et al, 2023, Genetics Research CrossRef
5. Application of Phage-Displayed Peptides in Tumor Imaging Diagnosis and Targeting Therapy
   Chunyan Li et al, 2021, International Journal of Peptide Research and Therapeutics CrossRef
6. EMT‐associated microRNAs and their roles in cancer stemness and drug resistance
   Guangtao Pan et al, 2021, Cancer Communications CrossRef
7. Modulated Electro-Hyperthermia Supports the Effect of Gemcitabine Both in Sensitive and Resistant Pancreas Adenocarcinoma Cell Lines
   Gertrud Forika et al, 2021, Pathology and Oncology Research CrossRef
8. Role of non-coding RNAs and RNA modifiers in cancer therapy resistance
   Xinyi Zhang et al, 2020, Molecular Cancer CrossRef
9. Noncoding RNAs: an emerging modulator of drug resistance in pancreatic cancer
   Ling Wei et al, 2023, Frontiers in Cell and Developmental Biology CrossRef